DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Dianthus Therapeutics, Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$74.54+2.45 (+3.40%)
Close on Oct 19, 2026
- Market cap
- $4.18B
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SEC filings
40 of Dianthus Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 21, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2025 | Apr 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2024 | Sep 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 23, 2024 | Apr 11, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 21, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 21, 2024 | SEC EDGAR |